rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2008-8-1
|
pubmed:abstractText |
Identification of prognostic factors for survival in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is necessary for appropriate monitoring, interventions, and timely referral for lung transplantation. Our objectives were (1) to identify factors associated with survival in SSc-PAH and (2) to evaluate the methodologic quality of prognostic studies against current standards.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1584-90
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18597400-Age Factors,
pubmed-meshheading:18597400-Female,
pubmed-meshheading:18597400-Genetic Predisposition to Disease,
pubmed-meshheading:18597400-HLA-DR Antigens,
pubmed-meshheading:18597400-HLA-DR Serological Subtypes,
pubmed-meshheading:18597400-HLA-DR6 Antigen,
pubmed-meshheading:18597400-Humans,
pubmed-meshheading:18597400-Hypertension, Pulmonary,
pubmed-meshheading:18597400-Male,
pubmed-meshheading:18597400-Prognosis,
pubmed-meshheading:18597400-Pulmonary Artery,
pubmed-meshheading:18597400-Scleroderma, Systemic,
pubmed-meshheading:18597400-Sex Factors,
pubmed-meshheading:18597400-Survival Analysis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension.
|
pubmed:affiliation |
University Health Network, University of Toronto, Toronto, ON, Canada.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|